Beam Therapeutics BEAM MA — Tax Credit Carryforward Amount

Similar metrics at other companies

MAZEMA — Tax Credit Carryforward Amount

$235K—

NOVTUS — Tax Credit Carryforward Amount

$1.5M—

MAZECA — Tax Credit Carryforward Amount

$10.87M—

MAZEMA — Tax Credit Carryforward Expiration Start Year

508.5—

MAZEMA — Tax Credit Carryforward Expiration End Year

509.5—

AMLXMA — Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration

$201M+67.6%

Questions, answered.

What is Beam Therapeutics's MA — tax credit carryforward amount?

Beam Therapeutics (BEAM) reported MA — tax credit carryforward amount of $36.4M in Q4 2025.

What does MA — tax credit carryforward amount mean?

Represents the total value of accumulated tax credits that a specific geographic or operational segment can apply against future tax liabilities. This metric reflects the company's ability to reduce future cash tax outflows by utilizing historical tax incentives. It serves as a key indicator of the segment's tax planning efficiency and potential future liquidity benefits.